Frec Markets’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2M Buy
3,825
+1,047
+38% +$536K 0.13% 147
2026
Q2
$1.38M Buy
2,778
+1,243
+81% +$551K 0.12% 140
2026
Q1
$685K Buy
1,535
+218
+17% +$102K 0.12% 176
2025
Q4
$597K Buy
+1,317
New +$568K 0.17% 108

Other funds holding VRTX

Frec Markets's VRTX Position: Q3 2026 in Review

Frec Markets increased its Vertex Pharmaceuticals (VRTX) stake by 38% in Q3 2026, buying an estimated $536K and bringing the position to 3,825 shares worth $2M. The position accounts for 0.13% of the portfolio, ranked #147.

Frec Markets first reported a position in VRTX in Q4 2025 and has held it in 4 quarters since. 1,798 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Frec Markets held 3,825 shares of Vertex Pharmaceuticals worth $2M as of Q3 2026.
  • Frec Markets bought 1,047 Vertex Pharmaceuticals shares in Q3 2026, an estimated $536K.
  • Vertex Pharmaceuticals made up 0.13% of Frec Markets's portfolio in Q3 2026, its #147 holding.
  • Frec Markets first reported a position in Vertex Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • 1,798 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Frec Markets's 13F filing for Q3 2026, filed 16 Nov 2026.